microdosing tirzepatide for inflammation GLP-1 autoimmune conditions: what the research actually shows GLP-1 Microdosing, Brain Health &

This continuous recirculation of toxins keeps the innate immune system in a constant state of high alert

The distinction between evidence-based pharmaceutical GLP-1 medications and unregulated patch products is critical for patient safety and treatment efficacy

Tirzepatide was consistently associated with greater loss of lean body mass than semaglutide

Control of mitochondrial metabolism and systemic energy homeostasis by microRNAs 378 and 378*

Overall, the combined metabolic, neurochemical, and immunomodulatory effects of GLP-1 RAs suggest they could offer therapeutic benefits in mood disorders, especially for patients with coexisting metabolic dysfunction or resistance to standard treatments [15,19,20]